Impact of the embryonic obesogenic environment on programming of cardiovascular diseases across the life course
OBESE-EMBRYO aims to improve cardiovascular health in future generations by targeting the embryonic obesogenic environment in overweight and obese parents-to-be through innovative, evidence-based interventions.
Projectdetails
Introduction
50% of all pregnancies occur in couples with overweight or obesity, leading to tremendous risks for pregnancy and long-term offspring cardiovascular complications. My hypothesis is that an embryonic obesogenic environment, induced by the mother and father-to-be, predisposes to placental and embryonic programming of cardiovascular diseases across the life course. This leads to the intergenerational cycle of the cardiovascular disease epidemic.
Current Challenges
Lifestyle interventions in pregnancy are emerging, but they have been unsuccessful in improving pregnancy or offspring cardiovascular outcomes due to:
- Inadequate timing
- Unclear intervention targets
- Unpredictable outcomes
Project Overview
OBESE-EMBRYO aims to radically improve care for overweight and obese parents-to-be by targeting the embryonic obesogenic environment to prevent the development of cardiovascular diseases in offspring. To fulfill this mission, OBESE-EMBRYO will provide crucial insights for evidence-based, personalized prevention and intervention strategies from preconception onwards.
Innovative Aspects
Beyond state-of-the-art aspects, OBESE-EMBRYO includes:
- First population-based study on preconception and early pregnancy as critical periods for adverse effects of an embryonic obesogenic environment, induced by the mother and father-to-be.
- Intergenerational metabolism studies using metabolomics and oral-glucose-tolerance tests to identify unknown metabolic pathways.
- Cutting-edge imaging studies of cardiovascular development from embryonic life into adulthood to identify unknown developmental adaptations.
- Longitudinal, repeated placental-miRNA studies throughout the first trimester, with an integrated approach to address replication, tissue specificity, and functionality.
- Translation of results into prediction models for offspring cardiovascular complications using Artificial Intelligence and an evidence-based clinical support system for overweight and obese parents-to-be.
Expected Impact
Expected results will have a great population impact on cardiovascular health in future generations.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.499.998 |
Totale projectbegroting | € 1.499.998 |
Tijdlijn
Startdatum | 1-1-2025 |
Einddatum | 31-12-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAMpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Mapping the behavioural causes of weight change variability with genetic lotteryThe OBECAUSE project aims to streamline obesity treatment predictions through a machine learning pipeline and genomic analysis, creating targeted interventions for effective weight loss. | ERC Starting... | € 1.497.500 | 2024 | Details |
Exercised breastmilk: a kick-start for childhood obesity preventionThis project aims to investigate how maternal exercise during lactation alters breastmilk composition and its potential impact on reducing infant obesity risk through randomized trials and multi-omics analysis. | ERC Starting... | € 1.891.529 | 2023 | Details |
Health Economic Impact of Population-based Interventions for Prevention of Overweight and ObesityEcIMPACT aims to evaluate the health and economic impacts of population-based interventions for obesity prevention using innovative data methods to inform effective health policy. | ERC Starting... | € 1.496.598 | 2026 | Details |
Unravelling specificity of epi-metabolic regulation in mouse developmentThis project aims to uncover how metabolic changes influence epigenetic outcomes during mouse embryo implantation, using multi-omic approaches and mechanistic experiments to explore regulatory processes. | ERC Starting... | € 1.500.000 | 2023 | Details |
Unraveling the etiology of congenital heart defects – The role of maternal genetics and cardiovascular disease as a risk factorThis project aims to investigate how maternal genetics and cardiovascular health influence the risk of congenital heart defects in offspring, utilizing extensive Finnish health data and biomarker analysis. | ERC Starting... | € 1.495.845 | 2023 | Details |
Mapping the behavioural causes of weight change variability with genetic lottery
The OBECAUSE project aims to streamline obesity treatment predictions through a machine learning pipeline and genomic analysis, creating targeted interventions for effective weight loss.
Exercised breastmilk: a kick-start for childhood obesity prevention
This project aims to investigate how maternal exercise during lactation alters breastmilk composition and its potential impact on reducing infant obesity risk through randomized trials and multi-omics analysis.
Health Economic Impact of Population-based Interventions for Prevention of Overweight and Obesity
EcIMPACT aims to evaluate the health and economic impacts of population-based interventions for obesity prevention using innovative data methods to inform effective health policy.
Unravelling specificity of epi-metabolic regulation in mouse development
This project aims to uncover how metabolic changes influence epigenetic outcomes during mouse embryo implantation, using multi-omic approaches and mechanistic experiments to explore regulatory processes.
Unraveling the etiology of congenital heart defects – The role of maternal genetics and cardiovascular disease as a risk factor
This project aims to investigate how maternal genetics and cardiovascular health influence the risk of congenital heart defects in offspring, utilizing extensive Finnish health data and biomarker analysis.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Preterm Brain-Oxygenation and Metabolic EU-Sensing: Feed the BrainPrometeus aims to personalize nutrition for premature neonates in NICUs through real-time adjustments of glucose and nutrients based on brain needs, reducing the risk of neurodevelopmental disabilities. | EIC Pathfinder | € 3.554.156 | 2023 | Details |
Preterm Brain-Oxygenation and Metabolic EU-Sensing: Feed the Brain
Prometeus aims to personalize nutrition for premature neonates in NICUs through real-time adjustments of glucose and nutrients based on brain needs, reducing the risk of neurodevelopmental disabilities.